Search

everythinglearnresearchcommunity

for

Search:↓

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

Minoxidil and spironolactone slow hair loss in women.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Spironolactone may help reduce hair loss in androgenic alopecia.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

Oral minoxidil effectively treats hair loss, with women needing lower doses (0.25 to 2.5 mg daily) and men needing higher doses (1.25 to 5 mg daily).

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Finasteride helps reduce hidradenitis suppurativa symptoms in females.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Finasteride increases hair count and improves hair growth with low risk of side effects.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

In 2017, Spanish dermatologists most often prescribed minoxidil and finasteride for male hair loss, and minoxidil and oral contraceptives for premenopausal female hair loss.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

New treatments for hair growth disorders are needed due to limited current options and complex hair follicle biology.

Eating high-glycemic and dairy foods can increase hormones that may cause acne and other health issues.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Good nutrition is crucial for health and preventing disease, and supplements can help prevent nutrient deficiencies.

Most acne patients were young males with face acne, with many experiencing worsening in summer and diet-related aggravation.